The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
The goal of this study is two-fold: to establish a tissue banking respository (defined as blood, urine, soft tissue, tumor specimen, and normal tissue from areas surrounding tumor specimens), and to prospectively assess health related quality of life (QOL) over time in patients with a pathologically confirmed diagnosis of neoplasia receiving radiotherapy or photodynamic therapy (PDT)
Condition or disease
Patients With Pathologically Confirmed Neoplasia That Have BeenSelected for Definitive Photodynamic Therapy, Proton, or PhotonRadiotherapy.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 89 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Donors will be between the ages of 18 and 89 with pathologically confirmed neoplasia that are selected for definitive photodynamic therapy, proton, photon radiotherapy
-Pediatric patients with pathologically confirmed neoplasia that have been selected for definitive radiotherapy may elect to participate in a pediatric arm of quality of life, provided that the proper processes of parental permission and assent have occurred.